Citigroup Inc Exagen Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$4.18 - $7.74 $3,486 - $6,455	-834 Reduced 90.06%	92 $1,000
Q1 2022 May 12, 2022	SELL	$7.12 - $11.06 $12,723 - $19,764	-1,787 Reduced 65.87%	926 $7,000
Q4 2021 Feb 10, 2022	BUY	$8.97 - $14.08 $14,621 - $22,950	1,630 Added 150.51%	2,713 $32,000
Q3 2021 Nov 10, 2021	BUY	$10.25 - $15.21 $11,100 - $16,472	1,083 New	1,083 $15,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.